Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03248869 · ClinicalTrials.gov registry record · NA
Asthma Mobile Health Application 2.0
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 7,752
- Enrollment target
NCT03248869: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03248869 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 7,752 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (453% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03248869, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,752 participants
- Enrollment target
Study Summary
Mobile health applications (MHA) are increasingly being explored as tools to assist in management of chronic diseases. Little is known regarding which characteristics of MHAs are effective and there is limited data suggesting a real-world impact on health outcomes. Asthma is one of the most common and costly of the chronic diseases, impacting a broad range of the population including both children and adults. It is a variable disease necessitating regular medication use, monitoring of symptoms, and avoidance of specific triggers. These characteristics of asthma make it a chronic disease that is particularly amenable to having an MHA facilitate active monitoring outside of periodic traditional medical visits. The study team has designed a MHA focused on asthma subjects to test the feasibility of an asthma mobile health application (AMHA). The AMHA 2.0 study is the result of a collaboration between MHA developers and Mount Sinai faculty with expertise in the fields of asthma, research design, data storage, and data analysis. AMHA 2.0 incorporated elements of usual clinical care (that may take place during typical office visits), such as medication reminders, a daily asthma diary to track asthma control (AC) and medication use, patient education and assessments of quality of life (QoL), and health care utilization (HCU).
Primary Outcome
Number of people who downloaded AMHA
Interventions
- OTHER Mobile Health App
- OTHER Current Daily Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,752 participants |
| Start Date | 2015-03-15 |
| Est. Completion | 2017-03-15 |
| Phase | NA |
What the finished NCT03248869 record still lists
NCT03248869 is an interventional study that assigns participants to a tested intervention. Its 7,752 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (453% higher).
The record links to 0 conditions, and to 2 interventions - of which Mobile Health App is the first listed.
NCT03248869 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03248869 about?
NCT03248869 is a clinical study titled "Asthma Mobile Health Application 2.0". Mobile health applications (MHA) are increasingly being explored as tools to assist in management of chronic diseases. Little is known regarding which characteristics of MHAs are effective and there is limited data suggesting a real-world impact on health outcomes. Asthma is one of the most common a...
What is the current status of trial NCT03248869?
This trial is currently completed. It is a NA study. The enrollment target is 7,752 participants. The study started on 2015-03-15. Estimated completion is 2017-03-15.
What interventions are being tested in trial NCT03248869?
The interventions under investigation include: Mobile Health App (OTHER), Current Daily Survey (OTHER).
Who is sponsoring clinical trial NCT03248869?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03248869's enrollment target sits among peer trials
7,752 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI